Efficacy and safety of CD19 CAR T constructed with a new anti-CD19 chimeric antigen receptor in relapsed or refractory acute lymphoblastic leukemia.

Runxia GuFang LiuDehui ZouYingxi XuYang LuBingcheng LiuWei LiuXiaojuan ChenKaiqi LiuYe GuoXiaoyuan GongRui LvXia ChenChunlin ZhouMengjun ZhongHuijun WangHui WeiYingchang MiLugui QiuLulu LvMin WangYing WangXiaofan ZhuJian-Xiang Wang

Published in: Journal of hematology & oncology (2020)

ClinicalTrials.gov : NCT02975687; registered 29 November, 2016. https://clinicaltrials.gov/ct2/keydates/NCT02975687.

Keyphrases

acute lymphoblastic leukemia
allogeneic hematopoietic stem cell transplantation
computed tomography
acute myeloid leukemia
nk cells
image quality
multiple myeloma
magnetic resonance imaging
contrast enhanced
positron emission tomography
magnetic resonance
pet ct